HIV Diagnosis Market by Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification, Product (Assay, Kit, Reagent, Instrument, Software, Services), End User (Hospitals) - Global Forecast to 2021
The HIV diagnosis market is projected to reach USD 3.88 billion by 2021 from USD 2.35 billion in 2016, at a CAGR of 10.5% from 2016 to 2021. The global HIV diagnosis market is segmented based on product, test type, end user, and region. On the basis of product, the market is segmented into consumables (assays, kits, reagents, and other consumables), instruments, and software & services. The consumable segment is expected to register the highest CAGR during the forecast period. The frequent and repetitive purchase of consumables by laboratories and hospitals, growing prevalence of HIV/AIDS, and increasing initiatives from governments to fight HIV/AIDS are some of the major factors driving the consumables market.
On the basis of test type, the market is segmented into antibody tests, viral load tests, CD4 count tests, tests for early infant diagnosis, and tests for viral identification. The antibody tests segment further divided into HIV-1 screening tests, HIV-1 confirmatory tests, and HIV-2 and group O diagnostic tests. The antibody tests segment is expected to account for the largest share of the HIV diagnosis market in 2016. These tests are widely adopted to screening and confirmation of HIV antibodies. Moreover, increasing prevalence of HIV/AIDS, increasing awareness about HIV, increasing blood donations and transfusions, and advancements in technology are expected to drive the growth of this market.
On the basis of end user, the HIV diagnosis market is divided into diagnostic laboratories, hospitals, blood banks, home care settings, and others (gene banks, cell banks, biotechnology and pharmaceutical companies, and academic research institutes). The diagnostic laboratories segment is expected to account for the largest share of HIV diagnosis market in 2016. Increasing awareness about HIV/AIDS and advancements in PoC instruments and consumables are major drivers for this end-user segment.
Geographically, North America dominates the global HIV diagnosis market. The government initiatives and funding in order to increase HIV diagnosis procedures and create awareness amongst the pollution and increasing number of blood transfusions are increasing the demand for HIV diagnosis products in North America.
The major factors contributing to the growth of the global HIV diagnosis market include the increasing prevalence of HIV/AIDS worldwide, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments & kits, and increasing government initiatives. On the other hand, the high cost of NAT and lack of mandates for NAT in developing countries are the major factors restraining the growth of this market. The high growth potential in the Asian region provides opportunities for players in the HIV diagnosis market.
The major players in the HIV diagnosis market are Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S), Danaher Corporation (U.S.), Thermo-Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Hologic, Inc. (U.S.), Alere Inc. (U.S.), and Bio-Rad Laboratories (U.S.).
Research Coverage
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by players to maintain and increase their shares in the market.
Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Companies purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
On the basis of test type, the market is segmented into antibody tests, viral load tests, CD4 count tests, tests for early infant diagnosis, and tests for viral identification. The antibody tests segment further divided into HIV-1 screening tests, HIV-1 confirmatory tests, and HIV-2 and group O diagnostic tests. The antibody tests segment is expected to account for the largest share of the HIV diagnosis market in 2016. These tests are widely adopted to screening and confirmation of HIV antibodies. Moreover, increasing prevalence of HIV/AIDS, increasing awareness about HIV, increasing blood donations and transfusions, and advancements in technology are expected to drive the growth of this market.
On the basis of end user, the HIV diagnosis market is divided into diagnostic laboratories, hospitals, blood banks, home care settings, and others (gene banks, cell banks, biotechnology and pharmaceutical companies, and academic research institutes). The diagnostic laboratories segment is expected to account for the largest share of HIV diagnosis market in 2016. Increasing awareness about HIV/AIDS and advancements in PoC instruments and consumables are major drivers for this end-user segment.
Geographically, North America dominates the global HIV diagnosis market. The government initiatives and funding in order to increase HIV diagnosis procedures and create awareness amongst the pollution and increasing number of blood transfusions are increasing the demand for HIV diagnosis products in North America.
The major factors contributing to the growth of the global HIV diagnosis market include the increasing prevalence of HIV/AIDS worldwide, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments & kits, and increasing government initiatives. On the other hand, the high cost of NAT and lack of mandates for NAT in developing countries are the major factors restraining the growth of this market. The high growth potential in the Asian region provides opportunities for players in the HIV diagnosis market.
The major players in the HIV diagnosis market are Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S), Danaher Corporation (U.S.), Thermo-Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Hologic, Inc. (U.S.), Alere Inc. (U.S.), and Bio-Rad Laboratories (U.S.).
Research Coverage
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by players to maintain and increase their shares in the market.
Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Companies purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the HIV diagnosis market. The report analyses the HIV diagnosis market by product, test type, end user, and region.
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the HIV diagnosis market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the HIV diagnosis market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for HIV diagnosis across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the HIV diagnosis market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 SECONDARY DATA
2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2 PRIMARY DATA
2.2.1 KEY DATA FROM PRIMARY SOURCES
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CONCLUSION
4 PREMIUM INSIGHTS
4.1 HIV DIAGNOSTICS: MARKET OVERVIEW
4.2 GEOGRAPHIC ANALYSIS: HIV DIAGNOSTICS MARKET, BY TEST TYPE (2016)
4.3 GEOGRAPHIC SNAPSHOT OF THE HIV DIAGNOSTICS MARKET
4.4 LIFE CYCLE ANALYSIS, BY REGION
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.1.1 DRIVERS
5.1.1.1 Growing worldwide prevalence of HIV/AIDS
5.1.1.2 Increasing number of blood transfusions and blood donations
5.1.1.3 Benefits offered by point-of-care instruments & kits
5.1.1.4 Increasing government initiatives
5.1.2 RESTRAINTS
5.1.2.1 High cost of NAT
5.1.2.2 Lack of mandates for NAT in developing countries
5.1.3 OPPORTUNITY
5.1.3.1 Emerging economies offer lucrative growth opportunities for HIV diagnostics
5.1.4 TREND
5.1.4.1 Increase in use of home access kits and instruments
6 HIV DIAGNOSTICS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 CONSUMABLES
6.2.1 ASSAYS AND KITS & REAGENTS
6.2.2 OTHER CONSUMABLES
6.3 INSTRUMENTS
6.4 SOFTWARE & SERVICES
7 HIV DIAGNOSTICS MARKET, BY TEST TYPE
7.1 INTRODUCTION
7.2 ANTIBODY TESTS
7.2.1 HIV-1 SCREENING TESTS
7.2.1.1 ELISA
7.2.1.2 Rapid tests
7.2.1.3 Home access dried blood spots
7.2.2 HIV-1 ANTIBODY CONFIRMATORY TESTS
7.2.2.1 Western blot tests
7.2.2.2 Indirect immunofluorescence assays (IFA)
7.2.2.3 Line immunoassays
7.2.2.4 Radio-immunoprecipitation assays
7.2.3 HIV-2 & GROUP O DIAGNOSTIC TESTS
7.3 VIRAL LOAD TESTS
7.4 CD4 TESTS
7.5 TESTS FOR EARLY INFANT DIAGNOSIS
7.6 TESTS FOR VIRAL IDENTIFICATION
8 HIV DIAGNOSTICS MARKET, BY END USER
8.1 INTRODUCTION
8.2 DIAGNOSTIC LABORATORIES
8.3 HOSPITALS
8.4 BLOOD BANKS
8.5 HOME CARE SETTINGS
8.6 OTHER END USERS
9 HIV DIAGNOSTICS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.3 EUROPE
9.4 ASIA
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 REST OF ASIA (ROA)
9.5 REST OF THE WORLD (ROW)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 STRATEGIC OVERVIEW
10.3 MARKET SHARE ANALYSIS
10.4 COMPETITIVE SITUATION AND TRENDS
10.4.1 PRODUCT LAUNCHES
10.4.2 AGREEMENTS, PARTNERSHIPS & COLLABORATIONS
10.4.3 EXPANSIONS
10.4.4 OTHER DEVELOPMENTS
11 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 INTRODUCTION
11.2 SIEMENS HEALTHINEERS (A DIVISION OF SIEMENS AG)
11.3 ROCHE DIAGNOSTICS (DIVISION OF HOFFMAN LA ROCHE LTD.)
11.4 ABBOTT LABORATORIES
11.5 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION)
11.6 THERMO-FISHER SCIENTIFIC INC.
11.7 MERCK KGAA
11.8 BECTON, DICKINSON & COMPANY
11.9 HOLOGIC INC.
11.10 ALERE INC.
11.11 BIO-RAD LABORATORIES
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 SECONDARY DATA
2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2 PRIMARY DATA
2.2.1 KEY DATA FROM PRIMARY SOURCES
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CONCLUSION
4 PREMIUM INSIGHTS
4.1 HIV DIAGNOSTICS: MARKET OVERVIEW
4.2 GEOGRAPHIC ANALYSIS: HIV DIAGNOSTICS MARKET, BY TEST TYPE (2016)
4.3 GEOGRAPHIC SNAPSHOT OF THE HIV DIAGNOSTICS MARKET
4.4 LIFE CYCLE ANALYSIS, BY REGION
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.1.1 DRIVERS
5.1.1.1 Growing worldwide prevalence of HIV/AIDS
5.1.1.2 Increasing number of blood transfusions and blood donations
5.1.1.3 Benefits offered by point-of-care instruments & kits
5.1.1.4 Increasing government initiatives
5.1.2 RESTRAINTS
5.1.2.1 High cost of NAT
5.1.2.2 Lack of mandates for NAT in developing countries
5.1.3 OPPORTUNITY
5.1.3.1 Emerging economies offer lucrative growth opportunities for HIV diagnostics
5.1.4 TREND
5.1.4.1 Increase in use of home access kits and instruments
6 HIV DIAGNOSTICS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 CONSUMABLES
6.2.1 ASSAYS AND KITS & REAGENTS
6.2.2 OTHER CONSUMABLES
6.3 INSTRUMENTS
6.4 SOFTWARE & SERVICES
7 HIV DIAGNOSTICS MARKET, BY TEST TYPE
7.1 INTRODUCTION
7.2 ANTIBODY TESTS
7.2.1 HIV-1 SCREENING TESTS
7.2.1.1 ELISA
7.2.1.2 Rapid tests
7.2.1.3 Home access dried blood spots
7.2.2 HIV-1 ANTIBODY CONFIRMATORY TESTS
7.2.2.1 Western blot tests
7.2.2.2 Indirect immunofluorescence assays (IFA)
7.2.2.3 Line immunoassays
7.2.2.4 Radio-immunoprecipitation assays
7.2.3 HIV-2 & GROUP O DIAGNOSTIC TESTS
7.3 VIRAL LOAD TESTS
7.4 CD4 TESTS
7.5 TESTS FOR EARLY INFANT DIAGNOSIS
7.6 TESTS FOR VIRAL IDENTIFICATION
8 HIV DIAGNOSTICS MARKET, BY END USER
8.1 INTRODUCTION
8.2 DIAGNOSTIC LABORATORIES
8.3 HOSPITALS
8.4 BLOOD BANKS
8.5 HOME CARE SETTINGS
8.6 OTHER END USERS
9 HIV DIAGNOSTICS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.3 EUROPE
9.4 ASIA
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 REST OF ASIA (ROA)
9.5 REST OF THE WORLD (ROW)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 STRATEGIC OVERVIEW
10.3 MARKET SHARE ANALYSIS
10.4 COMPETITIVE SITUATION AND TRENDS
10.4.1 PRODUCT LAUNCHES
10.4.2 AGREEMENTS, PARTNERSHIPS & COLLABORATIONS
10.4.3 EXPANSIONS
10.4.4 OTHER DEVELOPMENTS
11 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 INTRODUCTION
11.2 SIEMENS HEALTHINEERS (A DIVISION OF SIEMENS AG)
11.3 ROCHE DIAGNOSTICS (DIVISION OF HOFFMAN LA ROCHE LTD.)
11.4 ABBOTT LABORATORIES
11.5 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION)
11.6 THERMO-FISHER SCIENTIFIC INC.
11.7 MERCK KGAA
11.8 BECTON, DICKINSON & COMPANY
11.9 HOLOGIC INC.
11.10 ALERE INC.
11.11 BIO-RAD LABORATORIES
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
LIST OF TABLES
Table 1 GLOBAL HIV PREVALENCE, 2015
Table 2 GLOBAL HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 3 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014–2021 (USD MILLION)
Table 4 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY REGION, 2014–2021 (USD MILLION)
Table 5 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR ASSAYS AND KITS & REAGENTS, BY REGION, 2014–2021 (USD MILLION)
Table 6 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR OTHER CONSUMABLES, BY REGION, 2014–2021 (USD MILLION)
Table 7 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS, BY REGION, 2014–2021 (USD MILLION)
Table 8 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR SOFTWARE & SERVICES, BY REGION, 2014–2021 (USD MILLION)
Table 9 HIV DIAGNOSTICS MARKET SIZE, BY TYPE OF TEST, 2014–2021 (USD MILLION)
Table 10 HIV DIAGNOSTICS MARKET SIZE FOR ANTIBODY TESTS, BY TYPE, 2014–2021 (USD MILLION)
Table 11 HIV DIAGNOSTICS MARKET SIZE FOR ANTIBODY TESTS, BY REGION, 2014–2021 (USD MILLION)
Table 12 HIV-1 SCREENING TESTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 13 HIV-1 SCREENING TESTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 14 HIV-1 SCREENING TESTS MARKET SIZE FOR ELISA, BY REGION, 2014–2021 (USD MILLION)
Table 15 HIV-1 SCREENING TESTS MARKET SIZE FOR RAPID TESTS, BY REGION, 2014–2021 (USD MILLION)
Table 16 HIV-1 SCREENING TESTS MARKET SIZE FOR HOME ACCESS DRIED BLOOD SPOTS, BY REGION, 2014–2021 (USD MILLION)
Table 17 HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 18 HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 19 HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET SIZE FOR WESTERN BLOT TESTS, BY REGION, 2014–2021 (USD MILLION)
Table 20 HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET SIZE FOR INDIRECT IFA, BY REGION, 2014–2021 (USD MILLION)
Table 21 HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET SIZE FOR LINE IMMUNOASSAYS, BY REGION, 2014–2021 (USD MILLION)
Table 22 HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET SIZE FOR RADIO-IMMUNOPRECIPITATION ASSAYS, BY REGION, 2014–2021 (USD MILLION)
Table 23 HIV-2 & GROUP O DIAGNOSTIC TESTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 24 HIV DIAGNOSTICS MARKET SIZE FOR VIRAL LOAD TESTS, BY REGION, 2014–2021 (USD MILLION)
Table 25 HIV DIAGNOSTICS MARKET SIZE FOR CD4 TESTS, BY REGION, 2014–2021 (USD MILLION)
Table 26 HIV DIAGNOSTICS MARKET SIZE FOR TESTS FOR EARLY INFANT DIAGNOSIS, BY REGION, 2014–2021 (USD MILLION)
Table 27 HIV DIAGNOSTICS MARKET SIZE FOR TESTS FOR VIRAL IDENTIFICATION, BY REGION, 2014–2021 (USD MILLION)
Table 28 HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 29 GLOBAL HIV DIAGNOSTIC MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY REGION, 2014–2021 (USD MILLION)
Table 30 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR HOSPITALS, BY REGION, 2014–2021 (USD MILLION)
Table 31 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR BLOOD BANKS, BY REGION, 2014–2021 (USD MILLION)
Table 32 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR HOME CARE SETTINGS, BY REGION, 2014–2021 (USD MILLION)
Table 33 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY REGION, 2014–2021 (USD MILLION
Table 34 GLOBAL HIV DIAGNOSTICS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 35 NORTH AMERICA: HIV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 36 NORTH AMERICA: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 37 NORTH AMERICA: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 38 NORTH AMERICA: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 39 U.S.: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 40 U.S.: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 41 U.S.: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 42 CANADA: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 43 CANADA: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 44 CANADA: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 45 NUMBER OF HIV TESTS IN EUROPE, BY COUNTRY, 2014
Table 46 EUROPE: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 47 EUROPE: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 48 EUROPE: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 49 ASIA: HIV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 50 ASIA: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 51 ASIA: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 52 ASIA: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 53 CHINA: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 54 CHINA: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 55 CHINA: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 56 JAPAN: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 57 JAPAN: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 58 JAPAN: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 59 INDIA: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 60 INDIA: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 61 INDIA: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 62 ROA: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 63 ROA: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 64 ROA: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 65 ROW: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 66 ROW: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 67 ROW: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 68 GROWTH STRATEGY MATRIX, 2014–2016
Table 69 PRODUCT LAUNCHES, 2014–2016
Table 70 AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS, 2014–2016
Table 71 EXPANSIONS, 2014–2016
Table 72 OTHER DEVELOPMENTS, 2014–2016
Table 1 GLOBAL HIV PREVALENCE, 2015
Table 2 GLOBAL HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 3 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2014–2021 (USD MILLION)
Table 4 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY REGION, 2014–2021 (USD MILLION)
Table 5 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR ASSAYS AND KITS & REAGENTS, BY REGION, 2014–2021 (USD MILLION)
Table 6 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR OTHER CONSUMABLES, BY REGION, 2014–2021 (USD MILLION)
Table 7 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS, BY REGION, 2014–2021 (USD MILLION)
Table 8 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR SOFTWARE & SERVICES, BY REGION, 2014–2021 (USD MILLION)
Table 9 HIV DIAGNOSTICS MARKET SIZE, BY TYPE OF TEST, 2014–2021 (USD MILLION)
Table 10 HIV DIAGNOSTICS MARKET SIZE FOR ANTIBODY TESTS, BY TYPE, 2014–2021 (USD MILLION)
Table 11 HIV DIAGNOSTICS MARKET SIZE FOR ANTIBODY TESTS, BY REGION, 2014–2021 (USD MILLION)
Table 12 HIV-1 SCREENING TESTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 13 HIV-1 SCREENING TESTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 14 HIV-1 SCREENING TESTS MARKET SIZE FOR ELISA, BY REGION, 2014–2021 (USD MILLION)
Table 15 HIV-1 SCREENING TESTS MARKET SIZE FOR RAPID TESTS, BY REGION, 2014–2021 (USD MILLION)
Table 16 HIV-1 SCREENING TESTS MARKET SIZE FOR HOME ACCESS DRIED BLOOD SPOTS, BY REGION, 2014–2021 (USD MILLION)
Table 17 HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 18 HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 19 HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET SIZE FOR WESTERN BLOT TESTS, BY REGION, 2014–2021 (USD MILLION)
Table 20 HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET SIZE FOR INDIRECT IFA, BY REGION, 2014–2021 (USD MILLION)
Table 21 HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET SIZE FOR LINE IMMUNOASSAYS, BY REGION, 2014–2021 (USD MILLION)
Table 22 HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET SIZE FOR RADIO-IMMUNOPRECIPITATION ASSAYS, BY REGION, 2014–2021 (USD MILLION)
Table 23 HIV-2 & GROUP O DIAGNOSTIC TESTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 24 HIV DIAGNOSTICS MARKET SIZE FOR VIRAL LOAD TESTS, BY REGION, 2014–2021 (USD MILLION)
Table 25 HIV DIAGNOSTICS MARKET SIZE FOR CD4 TESTS, BY REGION, 2014–2021 (USD MILLION)
Table 26 HIV DIAGNOSTICS MARKET SIZE FOR TESTS FOR EARLY INFANT DIAGNOSIS, BY REGION, 2014–2021 (USD MILLION)
Table 27 HIV DIAGNOSTICS MARKET SIZE FOR TESTS FOR VIRAL IDENTIFICATION, BY REGION, 2014–2021 (USD MILLION)
Table 28 HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 29 GLOBAL HIV DIAGNOSTIC MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY REGION, 2014–2021 (USD MILLION)
Table 30 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR HOSPITALS, BY REGION, 2014–2021 (USD MILLION)
Table 31 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR BLOOD BANKS, BY REGION, 2014–2021 (USD MILLION)
Table 32 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR HOME CARE SETTINGS, BY REGION, 2014–2021 (USD MILLION)
Table 33 GLOBAL HIV DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY REGION, 2014–2021 (USD MILLION
Table 34 GLOBAL HIV DIAGNOSTICS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 35 NORTH AMERICA: HIV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 36 NORTH AMERICA: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 37 NORTH AMERICA: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 38 NORTH AMERICA: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 39 U.S.: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 40 U.S.: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 41 U.S.: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 42 CANADA: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 43 CANADA: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 44 CANADA: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 45 NUMBER OF HIV TESTS IN EUROPE, BY COUNTRY, 2014
Table 46 EUROPE: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 47 EUROPE: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 48 EUROPE: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 49 ASIA: HIV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 50 ASIA: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 51 ASIA: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 52 ASIA: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 53 CHINA: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 54 CHINA: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 55 CHINA: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 56 JAPAN: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 57 JAPAN: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 58 JAPAN: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 59 INDIA: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 60 INDIA: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 61 INDIA: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 62 ROA: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 63 ROA: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 64 ROA: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 65 ROW: HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014–2021 (USD MILLION)
Table 66 ROW: HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 67 ROW: HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 68 GROWTH STRATEGY MATRIX, 2014–2016
Table 69 PRODUCT LAUNCHES, 2014–2016
Table 70 AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS, 2014–2016
Table 71 EXPANSIONS, 2014–2016
Table 72 OTHER DEVELOPMENTS, 2014–2016
LIST OF FIGURES
Figure 1 GLOBAL HIV DIAGNOSTICS MARKET SEGMENTATION
Figure 2 HIV DIAGNOSTICS MARKET: RESEARCH DESIGN
Figure 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 4 HIV DIAGNOSTICS MARKET: BOTTOM-UP APPROACH
Figure 5 HIV DIAGNOSTICS MARKET: TOP-DOWN APPROACH
Figure 6 HIV DIAGNOSTICS MARKET: DATA TRIANGULATION METHODOLOGY
Figure 7 GLOBAL HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2016 VS. 2021 (USD MILLION)
Figure 8 GLOBAL HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2016 VS. 2021 (USD MILLION)
Figure 9 GLOBAL HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2016 VS. 2021 (USD MILLION)
Figure 10 GEOGRAPHICAL SNAPSHOT OF THE HIV DIAGNOSTICS MARKET
Figure 11 GLOBAL HIV DIAGNOSTICS MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD
Figure 12 ANTIBODY TESTS SEGMENT COMMANDED THE LARGEST SHARE OF THE GLOBAL HIV DIAGNOSTICS MARKET IN 2016
Figure 13 ASIA PROJECTED TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 14 ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES
Figure 15 HIV DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
Figure 16 HIV DIAGNOSTICS MARKET SEGMENTATION, BY PRODUCT
Figure 17 CONSUMABLES WERE THE LARGEST PRODUCT SEGMENT IN THE HIV DIAGNOSTICS MARKET IN 2016
Figure 18 ASSAYS AND KITS & REAGENTS WERE THE LARGEST PRODUCT SEGMENT IN 2016
Figure 19 HIV DIAGNOSTICS MARKET SEGMENTATION, BY TEST TYPE
Figure 20 ANTIBODY TESTS WERE THE LARGEST TEST SEGMENT IN THE HIV DIAGNOSTICS MARKET IN 2016
Figure 21 HIV-1 SCREENING TESTS DOMINATED THE HIV DIAGNOSTICS MARKET FOR ANTIBODY TESTS IN 2016
Figure 22 ELISA WAS THE LARGEST HIV-1 SCREENING TESTS SEGMENT IN 2016
Figure 23 WESTERN BLOT TESTS WERE THE LARGEST SEGMENT IN THE HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET IN 2016
Figure 24 DIAGNOSTIC LABORATORIES COMMANDED THE LARGEST MARKET SHARE IN 2016
Figure 25 GEOGRAPHIC SNAPSHOT: EMERGING MARKETS IN ASIA OFFER SIGNIFICANT GROWTH OPPORTUNITIES IN THE HIV DIAGNOSTICS MARKET
Figure 26 HIV DIAGNOSTICS MARKET IN ASIA TO REGISTER THE HIGHEST CAGR DURING FORECAST PERIOD
Figure 27 NORTH AMERICA: HIV DIAGNOSTICS MARKET SNAPSHOT
Figure 28 U.S. TO DOMINATE THE NORTH AMERICAN HIV DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
Figure 29 ANTIBODY TESTS DOMINATED THE NORTH AMERICAN HIV DIAGNOSTICS MARKET, BY TEST TYPE, IN 2016
Figure 30 VIRAL LOAD TESTS SEGMENT TO REGISTER THE HIGHEST CAGR IN THE U.S. HIV DIAGNOSTICS MARKET
Figure 31 ANTIBODY TESTS FORM THE LARGEST SEGMENT IN THE CANADIAN HIV DIAGNOSTICS MARKET IN 2016
Figure 32 MARKET FOR VIRAL LOAD TESTS IN EUROPE TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 33 CHINA DOMINATED THE ASIAN HIV DIAGNOSTICS MARKET IN 2016
Figure 34 ASIA: HIV DIAGNOSTICS MARKET SNAPSHOT
Figure 35 ANTIBODY TESTS ACCOUNTED FOR THE LARGEST SHARE OF THE ASIAN HIV DIAGNOSTICS MARKET IN 2016
Figure 36 ANTIBODY TESTS ACCOUNTED FOR THE LARGEST SHARE OF THE HIV DIAGNOSTICS MARKET IN CHINA IN 2016
Figure 37 ANTIBODY TESTS HELD THE LARGEST SHARE OF THE JAPANESE HIV DIAGNOSTICS MARKET IN 2016
Figure 38 ANTIBODY TESTS ACCOUNTED FOR THE LARGEST SHARE OF THE INDIAN HIV DIAGNOSTICS MARKET IN 2016
Figure 39 ANTIBODY TESTS HELD THE LARGEST SHARE OF THE ROA HIV DIAGNOSTICS MARKET IN 2016
Figure 40 ANTIBODY TESTS HELD THE LARGEST SHARE OF THE ROW HIV DIAGNOSTICS MARKET IN 2016
Figure 41 PRODUCT LAUNCH WAS THE KEY STRATEGY ADOPTED BY PLAYERS IN THE HIV DIAGNOSTICS MARKET
Figure 42 HIV DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
Figure 43 GEOGRAPHIC REVENUE MIX OF THE TOP SIX MARKET PLAYERS
Figure 44 SIEMENS AG: COMPANY SNAPSHOT (2016)
Figure 45 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2015)
Figure 46 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2015)
Figure 47 DANAHER CORPORATION: COMPANY SNAPSHOT (2015)
Figure 48 THERMO-FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2015)
Figure 49 MERCK KGAA: COMPANY SNAPSHOT (2015)
Figure 50 BECTON, DICKINSON & COMPANY.: COMPANY SNAPSHOT (2016)
Figure 51 HOLOGIC INC.: COMPANY SNAPSHOT (2016)
Figure 52 ALERE INC: COMPANY SNAPSHOT (2016)
Figure 53 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2015)
Figure 1 GLOBAL HIV DIAGNOSTICS MARKET SEGMENTATION
Figure 2 HIV DIAGNOSTICS MARKET: RESEARCH DESIGN
Figure 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 4 HIV DIAGNOSTICS MARKET: BOTTOM-UP APPROACH
Figure 5 HIV DIAGNOSTICS MARKET: TOP-DOWN APPROACH
Figure 6 HIV DIAGNOSTICS MARKET: DATA TRIANGULATION METHODOLOGY
Figure 7 GLOBAL HIV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2016 VS. 2021 (USD MILLION)
Figure 8 GLOBAL HIV DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2016 VS. 2021 (USD MILLION)
Figure 9 GLOBAL HIV DIAGNOSTICS MARKET SIZE, BY END USER, 2016 VS. 2021 (USD MILLION)
Figure 10 GEOGRAPHICAL SNAPSHOT OF THE HIV DIAGNOSTICS MARKET
Figure 11 GLOBAL HIV DIAGNOSTICS MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD
Figure 12 ANTIBODY TESTS SEGMENT COMMANDED THE LARGEST SHARE OF THE GLOBAL HIV DIAGNOSTICS MARKET IN 2016
Figure 13 ASIA PROJECTED TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 14 ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES
Figure 15 HIV DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
Figure 16 HIV DIAGNOSTICS MARKET SEGMENTATION, BY PRODUCT
Figure 17 CONSUMABLES WERE THE LARGEST PRODUCT SEGMENT IN THE HIV DIAGNOSTICS MARKET IN 2016
Figure 18 ASSAYS AND KITS & REAGENTS WERE THE LARGEST PRODUCT SEGMENT IN 2016
Figure 19 HIV DIAGNOSTICS MARKET SEGMENTATION, BY TEST TYPE
Figure 20 ANTIBODY TESTS WERE THE LARGEST TEST SEGMENT IN THE HIV DIAGNOSTICS MARKET IN 2016
Figure 21 HIV-1 SCREENING TESTS DOMINATED THE HIV DIAGNOSTICS MARKET FOR ANTIBODY TESTS IN 2016
Figure 22 ELISA WAS THE LARGEST HIV-1 SCREENING TESTS SEGMENT IN 2016
Figure 23 WESTERN BLOT TESTS WERE THE LARGEST SEGMENT IN THE HIV-1 ANTIBODY CONFIRMATORY TESTS MARKET IN 2016
Figure 24 DIAGNOSTIC LABORATORIES COMMANDED THE LARGEST MARKET SHARE IN 2016
Figure 25 GEOGRAPHIC SNAPSHOT: EMERGING MARKETS IN ASIA OFFER SIGNIFICANT GROWTH OPPORTUNITIES IN THE HIV DIAGNOSTICS MARKET
Figure 26 HIV DIAGNOSTICS MARKET IN ASIA TO REGISTER THE HIGHEST CAGR DURING FORECAST PERIOD
Figure 27 NORTH AMERICA: HIV DIAGNOSTICS MARKET SNAPSHOT
Figure 28 U.S. TO DOMINATE THE NORTH AMERICAN HIV DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
Figure 29 ANTIBODY TESTS DOMINATED THE NORTH AMERICAN HIV DIAGNOSTICS MARKET, BY TEST TYPE, IN 2016
Figure 30 VIRAL LOAD TESTS SEGMENT TO REGISTER THE HIGHEST CAGR IN THE U.S. HIV DIAGNOSTICS MARKET
Figure 31 ANTIBODY TESTS FORM THE LARGEST SEGMENT IN THE CANADIAN HIV DIAGNOSTICS MARKET IN 2016
Figure 32 MARKET FOR VIRAL LOAD TESTS IN EUROPE TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
Figure 33 CHINA DOMINATED THE ASIAN HIV DIAGNOSTICS MARKET IN 2016
Figure 34 ASIA: HIV DIAGNOSTICS MARKET SNAPSHOT
Figure 35 ANTIBODY TESTS ACCOUNTED FOR THE LARGEST SHARE OF THE ASIAN HIV DIAGNOSTICS MARKET IN 2016
Figure 36 ANTIBODY TESTS ACCOUNTED FOR THE LARGEST SHARE OF THE HIV DIAGNOSTICS MARKET IN CHINA IN 2016
Figure 37 ANTIBODY TESTS HELD THE LARGEST SHARE OF THE JAPANESE HIV DIAGNOSTICS MARKET IN 2016
Figure 38 ANTIBODY TESTS ACCOUNTED FOR THE LARGEST SHARE OF THE INDIAN HIV DIAGNOSTICS MARKET IN 2016
Figure 39 ANTIBODY TESTS HELD THE LARGEST SHARE OF THE ROA HIV DIAGNOSTICS MARKET IN 2016
Figure 40 ANTIBODY TESTS HELD THE LARGEST SHARE OF THE ROW HIV DIAGNOSTICS MARKET IN 2016
Figure 41 PRODUCT LAUNCH WAS THE KEY STRATEGY ADOPTED BY PLAYERS IN THE HIV DIAGNOSTICS MARKET
Figure 42 HIV DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
Figure 43 GEOGRAPHIC REVENUE MIX OF THE TOP SIX MARKET PLAYERS
Figure 44 SIEMENS AG: COMPANY SNAPSHOT (2016)
Figure 45 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2015)
Figure 46 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2015)
Figure 47 DANAHER CORPORATION: COMPANY SNAPSHOT (2015)
Figure 48 THERMO-FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2015)
Figure 49 MERCK KGAA: COMPANY SNAPSHOT (2015)
Figure 50 BECTON, DICKINSON & COMPANY.: COMPANY SNAPSHOT (2016)
Figure 51 HOLOGIC INC.: COMPANY SNAPSHOT (2016)
Figure 52 ALERE INC: COMPANY SNAPSHOT (2016)
Figure 53 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2015)
